Cameroon vs Lebanon: Access to anti-retroviral drugs, male
Cameroon
79.0%
in 2024
Lebanon
80.0%
in 2024
Cameroon rank
49th
Lebanon rank
47th
Access to anti-retroviral drugs, male over time
- Cameroon
- Lebanon
How they compare
Lebanon currently reports 80.0% against 79.0% in Cameroon, a difference of 1.0%.
Across all 25 years both countries report, Lebanon has been ahead every year.
Cameroon ranks 49th and Lebanon ranks 47th of 141 countries.
Lebanon has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Cameroon | Lebanon | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 4.7% | 19.1% | 14.4% | Lebanon |
| 2010s | 26.0% | 58.2% | 32.2% | Lebanon |
| 2020s | 68.2% | 82.4% | 14.2% | Lebanon |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Cameroon or Lebanon?
- Lebanon, at 80.0% against 79.0% in Cameroon as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Cameroon and Lebanon?
- 1.0%, with Lebanon ahead.
- How many years of comparable data are there for Cameroon and Lebanon?
- 25 years are reported by both, from 2000 to 2024.
- How do Cameroon and Lebanon rank globally for access to anti-retroviral drugs, male?
- Cameroon ranks 49th and Lebanon ranks 47th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.